A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation

Cancer and the fetal-placental semi-allograft share certain characteristics, e.g., rapid proliferation, the capacity to invade normal tissue, and, related to the presence of antigens foreign to the host, the need to evade immune surveillance. Many present-day methods to treat cancer use drugs that c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jerome H. Check, Diane L. Check
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d9a248a770754804ba6579e34c806d63
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9a248a770754804ba6579e34c806d63
record_format dspace
spelling oai:doaj.org-article:d9a248a770754804ba6579e34c806d632021-11-25T17:55:38ZA Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation10.3390/ijms2222123511422-00671661-6596https://doaj.org/article/d9a248a770754804ba6579e34c806d632021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12351https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Cancer and the fetal-placental semi-allograft share certain characteristics, e.g., rapid proliferation, the capacity to invade normal tissue, and, related to the presence of antigens foreign to the host, the need to evade immune surveillance. Many present-day methods to treat cancer use drugs that can block a key molecule that is important for one or more of these characteristics and thus reduce side effects. The ideal molecule would be one that is essential for both the survival of the fetus and malignant tumor, but not needed for normal cells. There is a potential suitable candidate, the progesterone induced blocking factor (PIBF). The parent 90 kilodalton (kDa) form seems to be required for cell-cycle regulation, required by both the fetal-placental unit and malignant tumors. The parent form may be converted to splice variants that help both the fetus and tumors escape immune surveillance, especially in the fetal and tumor microenvironment. Evidence suggests that membrane progesterone receptors are involved in PIBF production, and indeed there has been anecdotal evidence that progesterone receptor antagonists, e.g., mifepristone, can significantly improve longevity and quality of life, with few side effects.Jerome H. CheckDiane L. CheckMDPI AGarticleprogesterone receptorsprogesterone receptor modulatorsmalignant tumorstumor microenvironmentcellular immunitynatural killer cellsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12351, p 12351 (2021)
institution DOAJ
collection DOAJ
language EN
topic progesterone receptors
progesterone receptor modulators
malignant tumors
tumor microenvironment
cellular immunity
natural killer cells
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle progesterone receptors
progesterone receptor modulators
malignant tumors
tumor microenvironment
cellular immunity
natural killer cells
Biology (General)
QH301-705.5
Chemistry
QD1-999
Jerome H. Check
Diane L. Check
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
description Cancer and the fetal-placental semi-allograft share certain characteristics, e.g., rapid proliferation, the capacity to invade normal tissue, and, related to the presence of antigens foreign to the host, the need to evade immune surveillance. Many present-day methods to treat cancer use drugs that can block a key molecule that is important for one or more of these characteristics and thus reduce side effects. The ideal molecule would be one that is essential for both the survival of the fetus and malignant tumor, but not needed for normal cells. There is a potential suitable candidate, the progesterone induced blocking factor (PIBF). The parent 90 kilodalton (kDa) form seems to be required for cell-cycle regulation, required by both the fetal-placental unit and malignant tumors. The parent form may be converted to splice variants that help both the fetus and tumors escape immune surveillance, especially in the fetal and tumor microenvironment. Evidence suggests that membrane progesterone receptors are involved in PIBF production, and indeed there has been anecdotal evidence that progesterone receptor antagonists, e.g., mifepristone, can significantly improve longevity and quality of life, with few side effects.
format article
author Jerome H. Check
Diane L. Check
author_facet Jerome H. Check
Diane L. Check
author_sort Jerome H. Check
title A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
title_short A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
title_full A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
title_fullStr A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
title_full_unstemmed A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation
title_sort hypothetical model suggesting some possible ways that the progesterone receptor may be involved in cancer proliferation
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d9a248a770754804ba6579e34c806d63
work_keys_str_mv AT jeromehcheck ahypotheticalmodelsuggestingsomepossiblewaysthattheprogesteronereceptormaybeinvolvedincancerproliferation
AT dianelcheck ahypotheticalmodelsuggestingsomepossiblewaysthattheprogesteronereceptormaybeinvolvedincancerproliferation
AT jeromehcheck hypotheticalmodelsuggestingsomepossiblewaysthattheprogesteronereceptormaybeinvolvedincancerproliferation
AT dianelcheck hypotheticalmodelsuggestingsomepossiblewaysthattheprogesteronereceptormaybeinvolvedincancerproliferation
_version_ 1718411835356479488